Review article: albumin for circulatory support in patients with cirrhosis
暂无分享,去创建一个
[1] R. Bataller,et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study , 2002, Hepatology.
[2] F. Roudot-thoraval,et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study , 2002, Hepatology.
[3] R. Moreau,et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. , 2002, Gastroenterology.
[4] J. García‐Pagán,et al. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol. , 2002, Journal of hepatology.
[5] H. Bonkovsky,et al. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity. , 2001, Journal of hepatology.
[6] O. Moine,et al. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. , 2001, Acta gastro-enterologica Belgica.
[7] R. Bataller,et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. , 2000, Journal of hepatology.
[8] J. Henriksen,et al. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. , 2000, Liver.
[9] A. Gerbes,et al. Long‐term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine , 1999, Hepatology.
[10] J. Henriksen,et al. Increased arterial compliance in decompensated cirrhosis. , 1999, Journal of hepatology.
[11] M. Navasa,et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. , 1999, The New England journal of medicine.
[12] P. Angeli,et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide , 1999, Hepatology.
[13] V. Arroyo. Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment , 1999 .
[14] N. Mcintyre,et al. Oxford Textbook of Clinical Hepatology , 1999 .
[15] T. Berl,et al. Hyponatremia in cirrhosis: From pathogenesis to treatment , 1998, Hepatology.
[16] R. Schrier,et al. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. , 1998, The New England journal of medicine.
[17] L. Molina,et al. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis. , 1998, Journal of hepatology.
[18] W. Jiménez,et al. Tumor necrosis factor and interleukin‐6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality , 1998, Hepatology.
[19] W. Jiménez,et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion , 1998, Hepatology.
[20] R. Bataller,et al. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. , 1997, Journal of hepatology.
[21] W. Jiménez,et al. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. , 1997, Gastroenterology.
[22] W. Jiménez,et al. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo. , 1997, Journal of hepatology.
[23] B. Runyon. Historical Aspects of Treatment of Patients with Cirrhosis and Ascites , 1997, Seminars in liver disease.
[24] M. Navasa,et al. Bacterial Infections in Liver Disease , 1997, Seminars in liver disease.
[25] W. Jiménez,et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. , 1996, Gastroenterology.
[26] P. Angeli,et al. Cirrhosis and muscle cramps: Evidence of a causal relationship , 1996, Hepatology.
[27] J. Schölmerich,et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.
[28] J. Henriksen,et al. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. , 1995, Gastroenterology.
[29] W. Jiménez,et al. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. , 1995, Hepatology.
[30] J. Llovet,et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis , 1994, Hepatology.
[31] W. Abelmann. Hyperdynamic circulation in cirrhosis: A historical perspective , 1994, Hepatology.
[32] N. Kuriya,et al. Fetal bile acid metabolism during infancy: Analysis of 1β‐hydroxylated bile acids in urine, meconium and feces , 1994, Hepatology.
[33] G. Grassi,et al. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites. , 1994, Gastroenterology.
[34] R. Schrier,et al. Peripheral Arterial Vasodilation: Determinant of Functional Spectrum of Cirrhosis , 1994, Seminars in liver disease.
[35] V. Arroyo,et al. A European survey on the treatment of ascites in cirrhosis. , 1994, Journal of hepatology.
[36] W. Jiménez,et al. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study. , 1994, Journal of hepatology.
[37] R. Moreau,et al. Total effective vascular compliance in patients with cirrhosis: A study of the response to acute blood volume expansion , 1992, Hepatology.
[38] R. Terg,et al. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. , 1992, Journal of hepatology.
[39] S. Nijhawan,et al. Large Volume Paracentesis and Intravenous Dextran to Treat Tense Ascites , 1992, Journal of clinical gastroenterology.
[40] M. Ducreux,et al. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin]. , 1992, Gastroenterologie clinique et biologique.
[41] S. Badalamenti,et al. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites , 1991, Hepatology.
[42] J. Llach,et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. , 1990, Gastroenterology.
[43] Vicente Arroyo,et al. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.
[44] J. Llach,et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. , 1988, Gastroenterology.
[45] W. Jiménez,et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. , 1987, Gastroenterology.
[46] S. Bruno,et al. Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy. , 1987, Journal of hepatology.
[47] R. Carroll,et al. Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion. , 1979, Gastroenterology.
[48] M. Witte,et al. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. , 1971, Gastroenterology.
[49] W. Summerskill,et al. Effects of Changing Plasma Volume, Serum Albumin Concentration, and Plasma Osmolality on Renal Function in Cirrhosis , 1967 .
[50] S. Sherlock,et al. The effect of repeated albumin infusions in patients with cirrhosis. , 1962, The Lancet.
[51] S. Sherlock,et al. Electrolyte and circulatory changes in terminal liver failure. , 1956, Lancet.
[52] G. Parker. A New Stomach Clamp , 1950, Postgraduate medical journal.
[53] C. S. Davidson,et al. AN EVALUATION OF HUMAN SERUM ALBUMIN IN THE TREATMENT OF CIRRHOSIS OF THE LIVER. , 1949, The Journal of clinical investigation.
[54] C. S. Davidson,et al. The effect of human serum albumin, mercurial diuretics, and a low sodium diet on sodium excretion in patients with cirrhosis of the liver. , 1949, The Journal of clinical investigation.
[55] D. Earle,et al. THE EFFECTS OF INTRAVENOUS INJECTION OF CONCENTRATED HUMAN SERUM ALBUMIN UPON BLOOD PLASMA, ASCITES AND RENAL FUNCTIONS IN THREE PATIENTS WITH CIRRHOSIS OF THE LIVER. , 1948, The Journal of clinical investigation.
[56] H. Mankin,et al. The effects of intravenous injection of concentrated human serum albumin upon blood plasma, ascites and renal functions in three patients with cirrhosis of the liver. , 1948, The Journal of clinical investigation.
[57] H. Mankin,et al. OSMOTIC FACTORS INFLUENCING THE FORMATION OF ASCITES IN PATIENTS WITH CIRRHOSIS OF THE LIVER. , 1948, The Journal of clinical investigation.
[58] A. Patek,et al. SERUM PROTEINS IN CIRRHOSIS OF THE LIVER: I. RELATION TO PROGNOSIS AND TO FORMATION OF ASCITES , 1942 .